Your browser doesn't support javascript.
loading
[New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Case report].
Rumiantceva, D G; Urumova, M M; Erdes, S F.
Afiliação
  • Rumiantceva DG; Nasonova Research Institute of Rheumatology.
  • Urumova MM; Nasonova Research Institute of Rheumatology.
  • Erdes SF; Nasonova Research Institute of Rheumatology.
Ter Arkh ; 93(5): 71517, 2021 May 15.
Article em Ru | MEDLINE | ID: mdl-36286718
ABSTRACT
The novel coronavirus infection COVID-19 (SARS-CoV-2) is now known to cause a variety of extrapulmonary complications, including cardiovascular, neurological and dermatological complications, many of which occur or last several weeks after infection. We present a clinical case of a patient who first developed symptoms of ankylosing spondylitis 2 weeks after recovering from COVID-19. The patient was prescribed therapy in accordance with international and Russian recommendations for the management of patients with ankylosing spondylitis with a positive effect in the form of absence arthritis, enthesitis and reducing the inflammatory back pain.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / COVID-19 Idioma: Ru Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / COVID-19 Idioma: Ru Ano de publicação: 2021 Tipo de documento: Article